Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- IRMD
- Price
- 52.29
- Stock movement up
- +2.19 (4.37%)
- Company name
- Iradimed Co
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Devices
- Market cap
- 662.69M
- Ent value
- 621.79M
- Price/Sales
- 9.29
- Price/Book
- 7.94
- Div yield
- 1.15%
- Div growth
- -
- Growth years
- -
- FCF payout
- 145.71%
- Trailing P/E
- 35.58
- Forward P/E
- 29.88
- PEG
- -
- EPS growth
- 21.02%
- 1 year return
- 27.04%
- 3 year return
- 5.69%
- 5 year return
- 21.12%
- 10 year return
- 12.83%
Last updated: 2025-04-11
IRadimed Corporation offers steady revenue growth with 14 consecutive quarters of record revenue and a small dividend, despite recent stock price decline. Read more about IRMD stock here.
April 8, 2025
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
IRMD does not pay dividends or no data was received
IRADIMED CORPORATION (NASDAQ:IRMD) Q4 2024 Earnings Conference Call February 13, 2025 11:00 AM ETCompany ParticipantsRoger Susi - Founder, President and...
February 13, 2025
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 35.58 |
| Price to OCF | 28.14 |
| Price to FCF | 38.63 |
| Price to EBITDA | 30.19 |
| EV to EBITDA | 28.32 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 9.29 |
| Price to Book | 7.94 |
| EV to Sales | 8.72 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 12.67M |
| EPS (TTM) | 1.46 |
| FCF per share (TTM) | 1.34 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 71.31M |
| Gross profit (TTM) | 55.00M |
| Operating income (TTM) | 21.32M |
| Net income (TTM) | 18.63M |
| EPS (TTM) | 1.46 |
| EPS (1y forward) | 1.75 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 77.14% |
| Operating margin (TTM) | 29.91% |
| Profit margin (TTM) | 26.12% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 51.72M |
| Net receivables | 10.36M |
| Total current assets | 74.29M |
| Goodwill | 0.00 |
| Intangible assets | 2.89M |
| Property, plant and equipment | 18.88M |
| Total assets | 94.25M |
| Accounts payable | 1.40M |
| Short/Current long term debt | 264.07K |
| Total current liabilities | 8.06M |
| Total liabilities | 10.81M |
| Shareholder's equity | 83.43M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 23.55M |
| Capital expenditures (TTM) | 6.39M |
| Free cash flow (TTM) | 17.16M |
| Dividends paid (TTM) | 25.00M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 22.33% |
| Return on Assets | 19.76% |
| Return on Invested Capital | 22.26% |
| Cash Return on Invested Capital | 20.50% |
IRADIMED CORPORATION. (NASDAQ:IRMD) Q3 2024 Earnings Conference Call October 31, 2024 11:00 AM ETCompany ParticipantsRoger Susi - President and Chief...
October 31, 2024
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 50.50 |
| Daily high | 52.53 |
| Daily low | 49.28 |
| Daily Volume | 58K |
| All-time high | 62.67 |
| 1y analyst estimate | 60.00 |
| Beta | 0.80 |
| EPS (TTM) | 1.46 |
| Dividend per share | 0.60 |
| Ex-div date | 24 Feb 2025 |
| Next earnings date | 30 Apr 2025 |
Downside potential
Loading...
Downside potential data
| IRMD | S&P500 | |
| Current price drop from All-time high | -16.56% | -12.89% |
| Highest price drop | -75.83% | -56.47% |
| Date of highest drop | 5 Apr 2017 | 9 Mar 2009 |
| Avg drop from high | -30.89% | -11.07% |
| Avg time to new high | 30 days | 12 days |
| Max time to new high | 720 days | 1805 days |
iO Charts is a Seeking Alpha partner
IRADIMED CORPORATION (NASDAQ:IRMD) Q2 2024 Results Conference Call August 1, 2024 12:00 PM ETCompany ParticipantsRoger Susi - President and Chief Executive...
August 3, 2024
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
662.69M
Marketcap category
Small-cap
Description
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Employees
148
Website
Investor relations
-
SEC filings
CEO
Leslie McDonnell
Country
USA
City
Winter Springs
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
IRADIMED CORPORATION (NASDAQ:IRMD) Q1 2024 Results Conference Call May 2, 2024 11:00 AM ETCompany ParticipantsRoger Susi - President and Chief Executive...
May 4, 2024
IRadimed Corporation (NASDAQ:IRMD) Q4 2023 Earnings Conference Call February 8, 2024 9:00 AM ETCompany ParticipantsRoger Susi - President and Chief...
February 8, 2024
iO Charts is a Seeking Alpha partnerNext page